SoftMedx Healthcare Income Statement

Financials in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	68.24	54.64	51.34	33.77	1.7
Revenue Growth (YoY)	24.90%	6.43%	52.05%	1887.34%	-82.33%
Cost of Revenue	45.65	36.24	30.22	20.03	0.91
Gross Profit	22.59	18.4	21.13	13.74	0.79
Selling, General & Admin	11.07	9.84	15.09	23.02	21.84
Operating Expenses	11.07	9.84	15.09	23.02	21.84
Operating Income	11.52	8.56	6.04	-9.28	-21.05
Interest Expense	-1.4	-1.32	-12.94	-15.55	-16.27
Interest & Investment Income	-	0.19	0.36	0.04	0
Currency Exchange Gain (Loss)	-	8.04	4.2	8.79	-
Other Non Operating Income (Expenses)	2.16	1.07	2.36	0.22	7.39
EBT Excluding Unusual Items	12.28	16.54	0.02	-15.78	-29.93
Gain (Loss) on Sale of Investments	-2.82	-16.61	19.08	-0.73	-2.74
Gain (Loss) on Sale of Assets	-	-	-4.73	-	7.95
Asset Writedown	-	-	-	-0.35	-
Other Unusual Items	-0.02	328.03	-	0.22	-
Pretax Income	9.45	327.95	14.37	-16.63	-24.72
Income Tax Expense	2.5	1.64	1.86	2.59	-
Earnings From Continuing Operations	6.95	326.32	12.51	-19.23	-24.72
Net Income to Company	6.95	326.32	12.51	-19.23	-24.72
Minority Interest in Earnings	-	-	-	-	-1.56
Net Income	6.95	326.32	12.51	-19.23	-26.28
Net Income to Common	6.95	326.32	12.51	-19.23	-26.28
Net Income Growth	-97.87%	2508.24%	-	-	-
Shares Outstanding (Basic)	579	326	326	326	326
Shares Outstanding (Diluted)	579	326	326	326	326
Shares Change (YoY)	77.64%	-	-	-	-
EPS (Basic)	0.01	1.00	0.04	-0.06	-0.08
EPS (Diluted)	0.01	1.00	0.04	-0.06	-0.08
EPS Growth	-98.80%	2508.30%	-	-	-
Free Cash Flow	-	3.88	-4.49	-3.38	-7.14
Free Cash Flow Per Share	-	0.01	-0.01	-0.01	-0.02
Gross Margin	33.11%	33.67%	41.15%	40.68%	46.50%
Operating Margin	16.89%	15.67%	11.76%	-27.50%	-1238.79%
Profit Margin	10.18%	597.22%	24.37%	-56.94%	-1546.50%
Free Cash Flow Margin	-	7.10%	-8.75%	-10.00%	-420.36%
EBITDA	11.7	8.73	6.26	-8.95	-20.83
EBITDA Margin	17.14%	15.98%	12.20%	-26.51%	-
D&A For EBITDA	0.17	0.17	0.23	0.33	0.21
EBIT	11.52	8.56	6.04	-9.28	-21.05
EBIT Margin	16.89%	15.67%	11.76%	-27.50%	-
Effective Tax Rate	26.44%	0.50%	12.93%	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.